SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-14-017890
Filing Date
2014-10-03
Accepted
2014-10-02 18:05:11
Documents
4
Period of Report
2014-11-11
Effectiveness Date
2014-10-03

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A bota20141002_def14a.htm DEF 14A 582076
2 proxycard.jpg GRAPHIC 168657
3 russsig.jpg GRAPHIC 2955
4 patti.jpg GRAPHIC 3961
  Complete submission text file 0001437749-14-017890.txt   825677
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 141137844
SIC: 2836 Biological Products, (No Diagnostic Substances)